Gain on retained interest in Sandisk
Neurocrine Biosciences Gain on retained interest in Sandisk decreased by 17.3% to $25.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 182.7%, from -$30.60M to $25.30M. Over 3 years (FY 2021 to FY 2024), Gain on retained interest in Sandisk shows a downward trend with a 21.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher values indicate favorable market conditions for the company's equity holdings, while lower values indicate market downturns.
Detailed definition
Reflects the change in fair value of specific equity securities that are required to be measured at fair value through n...
Peer comparison
Commonly reported as Change in Fair Value of Equity Securities at peer insurance companies.
other_income_expense_equity_securities_fv_ni_unrealized__27c10cHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$8.20M | $28.40M | $19.90M | -$7.40M | $11.10M | $7.20M | $2.20M | $37.30M | -$40.10M | $29.00M | $1.60M | -$19.90M | -$16.90M | -$1.90M | -$30.60M | -$6.70M | $30.60M | $25.30M |
| QoQ Change | — | — | +446.3% | -29.9% | -137.2% | +250.0% | -35.1% | -69.4% | >999% | -207.5% | +172.3% | -94.5% | <-999% | +15.1% | +88.8% | <-999% | +78.1% | +556.7% | -17.3% |
| YoY Change | — | — | — | — | — | +235.4% | -74.6% | -88.9% | +604.1% | -461.3% | +302.8% | -27.3% | -153.4% | +57.9% | -106.6% | <-999% | +66.3% | +281.1% | +182.7% |
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|
| Reportable Segment | -$30.60M | -$6.70M | $30.60M | $25.30M |
| Total | -$30.60M | -$6.70M | $30.60M | $25.30M |
Gain on retained interest in Sandisk at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's gain on retained interest in sandisk?
- Neurocrine Biosciences (NBIX) reported gain on retained interest in sandisk of $25.30M in Q1 2026.
- How has Neurocrine Biosciences's gain on retained interest in sandisk changed year-over-year?
- Neurocrine Biosciences's gain on retained interest in sandisk increased by 182.7% year-over-year, from -$30.60M to $25.30M.
- What is the long-term trend for Neurocrine Biosciences's gain on retained interest in sandisk?
- Over 3 years (2021 to 2024), Neurocrine Biosciences's gain on retained interest in sandisk has grown at a 21.1% compound annual growth rate (CAGR), from $20.90M to -$37.10M.
- What does gain on retained interest in sandisk mean?
- Unrealized gains or losses on equity securities that impact net income.